Do High Frequency Oscillation Vests Reduce Vital Capacity in Normal Subjects? by Hughett, Brad et al.
Boise State University
ScholarWorks
Podium Presentations 2010 Undergraduate Research and ScholarshipConference
4-12-2010
Do High Frequency Oscillation Vests Reduce Vital
Capacity in Normal Subjects?
Brad Hughett
Department of Respiratory Care, Boise State University
Colleen Monteith
Department of Respiratory Care, Boise State University
Vida Khaliki
Department of Respiratory Care, Boise State University
DO HIGH FREQUENCY OSCILLATION VESTS REDUCE VITAL CAPACITY IN NORMAL 
SUBJECTS? 
 
 
Team Members: Brad Hughett, Colleen Monteith, and Vida Khaliki        
Department of Respiratory Care, College of Health Sciences 
Faculty Sponsor: Jody Lester 
 
Background:  High frequency oscillation vests are an important therapy in numerous disease states.  The 
therapy vests physically compress and shake the chest serving to loosen and mobilize pulmonary 
secretions.  Aerosolized medications are frequently delivered concurrently with vest therapy. Patients 
receiving aerosolized medications are instructed to breathe deeply. However, the design and operation 
of the vest may affect a patient's ability to do so.  It is our hypothesis that a healthy person’s vital 
capacity (VC) will decrease with the use of these vests at medium and high pressure and frequency 
settings.  
Method: Our study used four subjects with healthy lungs.  We obtained a baseline slow VC using a 
Medical Graphics Corporation 1085/D Spirometer calibrated following American Thoracic Society 
guidelines and using BreezeSuite 6.2 software, these measurements served as our control.  Participants 
were then fitted with the Vest ®Airway Clearance System:  Model number 104 and slow VC 
measurements were repeated.  We performed measurements at medium settings of 15 Hz, 6 or 60% 
pressure and high settings of 20 Hz and 9 or 90% pressure.  Subjects wore a thin single layer of cotton 
clothing and were sitting throughout testing.  This process was then repeated using the inCourage™ 
RespirTech   Model number ICS-IM-US .  Manufactures specific full vests, tubing, and connections were 
used and fitted according to manufacturer’s instruction for both the inCourage™ and the Vest ®Airway 
Clearance Systems.  Results: See Table 1 
 
Conclusion:  The VC of all subjects was lower when wearing the high frequency oscillation devices.  The VC of 
subject three was significantly reduced.  In most cases the high pressure settings resulted in the lowest VC 
measurements.  VC reductions ranged from 50cc’s to 1380 cc’s.  We were unable to easily explain the large 
reduction in VC for subject 3, as vest fit was correct and similar to other subjects and four VC measurements 
demonstrated reproducibility.  These reductions may be clinically significant.  Further testing is required to fully 
realize the impact of combining high frequency chest oscillation vests with nebulized medication therapy. 
 
 Subject One Subject Two Subject Three Subject Four 
 Baseline VC 3.98 L  96%* 4.52 L  108% 4.54 L  110% 5.39L  105% 
The Vest ®Airway 
Clearance System 
Frequency 15Hz 
Pressure 6 
VC ↓ 
140cc  
92% VC ↓ 
210 cc  
103% VC ↓ 810 
cc  
91% VC ↓ 
510 cc  
95% 
Frequency 20Hz 
Pressure 9 
VC ↓ 
170 cc  
91% VC ↓ 
210 cc  
103% VC ↓ 890 
cc  
89% VC ↓ 
620 cc  
93% 
RespirTech 
inCourage™ 
Frequency 15Hz 
Pressure 60% 
VC↓ 
110 cc  
93% VC ↓ 50 
cc  
107% VC ↓ 780 
cc  
92% VC ↓ 
350 cc  
98% 
Frequency 20Hz 
Pressure 90% 
VC ↓ 
240 cc  
90% VC ↓ 
260 cc  
102% VC ↓ 
1380 cc  
77% VC ↓ 
460 cc  
96% 
*All percentages are % of predicted Vital Capacity 
